CITI/CALL/PFIZER INC/44/0.1/20.06.24 | Market Closed - Deutsche Boerse AG 18:38:10 31/05/2024 BST | ||
| 0.001 EUR | -.--% |
|
| 6 months | -90.91% | ||
| Current year | -87.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 0.001 | -.--% |
| 30/05/24 | 0.001 | -.--% |
| 29/05/24 | 0.001 | -.--% |
| 28/05/24 | 0.001 | -.--% |
| 27/05/24 | 0.001 | -.--% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 06:38 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Citi
|
| WKN | KG7EX4 |
| ISIN | DE000KG7EX43 |
| Date issued | 31/08/2022 |
| Strike | 44 $ |
| Maturity | 20/06/2024 (18 Days) |
| Parity | 10 : 1 |
| Emission price | 0.83 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.34 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Warrants
- Warrant
